Ubiquitin chain editing revealed by polyubiquitin linkage-specific antibodies - PubMed (original) (raw)
. 2008 Aug 22;134(4):668-78.
doi: 10.1016/j.cell.2008.07.039.
Marissa L Matsumoto, Ingrid E Wertz, Donald S Kirkpatrick, Jennie R Lill, Jenille Tan, Debra Dugger, Nathaniel Gordon, Sachdev S Sidhu, Frederic A Fellouse, Laszlo Komuves, Dorothy M French, Ronald E Ferrando, Cynthia Lam, Deanne Compaan, Christine Yu, Ivan Bosanac, Sarah G Hymowitz, Robert F Kelley, Vishva M Dixit
Affiliations
- PMID: 18724939
- DOI: 10.1016/j.cell.2008.07.039
Free article
Ubiquitin chain editing revealed by polyubiquitin linkage-specific antibodies
Kim Newton et al. Cell. 2008.
Free article
Abstract
Posttranslational modification of proteins with polyubiquitin occurs in diverse signaling pathways and is tightly regulated to ensure cellular homeostasis. Studies employing ubiquitin mutants suggest that the fate of polyubiquitinated proteins is determined by which lysine within ubiquitin is linked to the C terminus of an adjacent ubiquitin. We have developed linkage-specific antibodies that recognize polyubiquitin chains joined through lysine 63 (K63) or 48 (K48). A cocrystal structure of an anti-K63 linkage Fab bound to K63-linked diubiquitin provides insight into the molecular basis for specificity. We use these antibodies to demonstrate that RIP1, which is essential for tumor necrosis factor-induced NF-kappaB activation, and IRAK1, which participates in signaling by interleukin-1beta and Toll-like receptors, both undergo polyubiquitin editing in stimulated cells. Both kinase adaptors initially acquire K63-linked polyubiquitin, while at later times K48-linked polyubiquitin targets them for proteasomal degradation. Polyubiquitin editing may therefore be a general mechanism for attenuating innate immune signaling.
Similar articles
- Lysine 63 polyubiquitination in immunotherapy and in cancer-promoting inflammation.
Martinez-Forero I, Rouzaut A, Palazon A, Dubrot J, Melero I. Martinez-Forero I, et al. Clin Cancer Res. 2009 Nov 15;15(22):6751-7. doi: 10.1158/1078-0432.CCR-09-1225. Epub 2009 Nov 3. Clin Cancer Res. 2009. PMID: 19887490 Review. - If the prophet does not come to the mountain: dynamics of signaling complexes in NF-kappaB activation.
Kovalenko A, Wallach D. Kovalenko A, et al. Mol Cell. 2006 May 19;22(4):433-6. doi: 10.1016/j.molcel.2006.05.002. Mol Cell. 2006. PMID: 16713572 Review. - The K48-K63 Branched Ubiquitin Chain Regulates NF-κB Signaling.
Ohtake F, Saeki Y, Ishido S, Kanno J, Tanaka K. Ohtake F, et al. Mol Cell. 2016 Oct 20;64(2):251-266. doi: 10.1016/j.molcel.2016.09.014. Epub 2016 Oct 13. Mol Cell. 2016. PMID: 27746020 - Controlled synthesis of polyubiquitin chains.
Pickart CM, Raasi S. Pickart CM, et al. Methods Enzymol. 2005;399:21-36. doi: 10.1016/S0076-6879(05)99002-2. Methods Enzymol. 2005. PMID: 16338346 - Engineering and structural characterization of a linear polyubiquitin-specific antibody.
Matsumoto ML, Dong KC, Yu C, Phu L, Gao X, Hannoush RN, Hymowitz SG, Kirkpatrick DS, Dixit VM, Kelley RF. Matsumoto ML, et al. J Mol Biol. 2012 May 4;418(3-4):134-44. doi: 10.1016/j.jmb.2011.12.053. Epub 2011 Dec 29. J Mol Biol. 2012. PMID: 22227388
Cited by
- Ubiquitin chain conformation regulates recognition and activity of interacting proteins.
Ye Y, Blaser G, Horrocks MH, Ruedas-Rama MJ, Ibrahim S, Zhukov AA, Orte A, Klenerman D, Jackson SE, Komander D. Ye Y, et al. Nature. 2012 Dec 13;492(7428):266-70. doi: 10.1038/nature11722. Epub 2012 Dec 2. Nature. 2012. PMID: 23201676 Free PMC article. - RIPK3 contributes to TNFR1-mediated RIPK1 kinase-dependent apoptosis in conditions of cIAP1/2 depletion or TAK1 kinase inhibition.
Dondelinger Y, Aguileta MA, Goossens V, Dubuisson C, Grootjans S, Dejardin E, Vandenabeele P, Bertrand MJ. Dondelinger Y, et al. Cell Death Differ. 2013 Oct;20(10):1381-92. doi: 10.1038/cdd.2013.94. Epub 2013 Jul 26. Cell Death Differ. 2013. PMID: 23892367 Free PMC article. - TRAF1 Coordinates Polyubiquitin Signaling to Enhance Epstein-Barr Virus LMP1-Mediated Growth and Survival Pathway Activation.
Greenfeld H, Takasaki K, Walsh MJ, Ersing I, Bernhardt K, Ma Y, Fu B, Ashbaugh CW, Cabo J, Mollo SB, Zhou H, Li S, Gewurz BE. Greenfeld H, et al. PLoS Pathog. 2015 May 21;11(5):e1004890. doi: 10.1371/journal.ppat.1004890. eCollection 2015 May. PLoS Pathog. 2015. PMID: 25996949 Free PMC article. - A20: from ubiquitin editing to tumour suppression.
Hymowitz SG, Wertz IE. Hymowitz SG, et al. Nat Rev Cancer. 2010 May;10(5):332-41. doi: 10.1038/nrc2775. Epub 2010 Apr 12. Nat Rev Cancer. 2010. PMID: 20383180 Review. - Deciphering the complexity of Toll-like receptor signaling.
Ostuni R, Zanoni I, Granucci F. Ostuni R, et al. Cell Mol Life Sci. 2010 Dec;67(24):4109-34. doi: 10.1007/s00018-010-0464-x. Epub 2010 Jul 31. Cell Mol Life Sci. 2010. PMID: 20680392 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous